Copyright © Inderes 2011 - present. All rights reserved.
Log in to receive notifications.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Oriola

1.12

 

EUR

 

-1.41 %

7,686 following

OKDBV

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Compare
OKDBV
OMXHPI
Volume
1.201.201.101.101.001.000.900.900.800.802024-05-012024-05-012024-06-012024-06-012024-07-012024-07-012024-08-012024-08-012024-09-012024-09-012024-10-012024-10-012024-11-012024-11-012024-12-012024-12-012025-01-012025-01-012025-02-012025-02-012025-03-012025-03-012025-04-012025-04-011.150.88
-1.41%
+15.7%
+25.84%
+25.84%
+21.74%
+13.36%
-39.33%
-32.37%
-39.11%

Oriola is a pharmaceutical group with a special focus on the distribution of pharmaceuticals to other companies in the industry. The company offers services to pharmacies and other pharmaceutical companies, which includes, for example, negotiations with suppliers and distribution of products. The largest presence is in the Nordic and Baltic countries. The head office is located in Espoo.

Read more
Market cap
203.26M EUR
Turnover
11.53K EUR
P/E (adj.) (25e)
17.02
EV/EBIT (adj.) (25e)
5.36
P/B (25e)
1.61
EV/S (25e)
0.07
Dividend yield-% (25e)
6.25 %
Coverage
Recommendation
Accumulate
Target price
1.05 EUR
Updated
2025-03-05
Disclaimer
Rauli Juva
Rauli Juva

Analyst

Revenue and EBIT-%
2211001.91.11.31.31.31.422222323242425e25e26e26e27e27e

Revenue B

EBIT-% (adj.)

EPS and dividend
0.10.10.1-0-0-0.1-0.13.57.67.76.36.36.322222323242425e25e26e26e27e27e

EPS (adj.)

Dividend %

Financial calendar
2/4
2025

General meeting '25

3/4
2025

Annual dividend

29/4
2025

Interim report Q1'25

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Regulatory press release3/12/2025, 8:00 AM

Oriola Oyj: Oriola's Annual Report 2024 published

Oriola
Press release3/7/2025, 11:00 AM

Oriola Oyj: Oriola's sale of Svensk dos AB to Apotekstjänst Sverige AB proceeds - sale expected to be completed in Q2 2025

Oriola
Oriola Q4’24: Write-down weighed on reported earnings
Video3/4/2025, 11:36 AM by
Rauli Juva

Oriola Q4’24: Write-down weighed on reported earnings

Oriola's Q4 earnings were largely in line with expectations, but the reported earnings were weighed down by the previously announced write-down. The company guides for improved earnings this year.

Oriola

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release3/4/2025, 10:00 AM

Oriola Oyj: Notice to Oriola Corporation's Annual General Meeting 2025

Oriola
Oriola, Webcast, Q4'24
Webcast3/4/2025, 8:00 AM

Oriola, Webcast, Q4'24

Oriola
Regulatory press release3/4/2025, 6:30 AM

Oriola Oyj: Oriola Corporation's Financial Statements Release 1 January-31 December 2024

Oriola
Regulatory press release3/3/2025, 5:50 PM

Oriola Oyj: Oriola's Board of Directors recommends that the shareholder's proposal regarding combination of share classes and directed issuance of shares without payment be accepted at the Annual General Meeting

Oriola
Regulatory press release3/3/2025, 7:30 AM

Oriola Oyj: Oriola appoints Stig Tornell as Executive Vice President, Sales

Oriola
Press release2/18/2025, 7:00 AM

Oriola Oyj: Oriola Corporation to publish its Financial Statements Release 2024 on 4 March 2025

Oriola
Regulatory press release2/7/2025, 1:30 PM

Oriola Oyj: Oriola Corporation's shareholder's demand for including combination of share classes and directed issuance of shares without payment in the agenda of the Annual General Meeting

Oriola
Press release1/27/2025, 2:00 PM

Oriola Oyj: Oriola acquires MedInfo ApS in Denmark to strengthen its Nordic footprint in medical information and patient support programmes

Oriola
Regulatory press release1/23/2025, 8:00 AM

Oriola Oyj: Proposals of the Shareholders' Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2025 Annual General Meeting

Oriola
Regulatory press release12/19/2024, 12:00 PM

Oriola Oyj: Oriola to record an impairment of approximately EUR 16 million related to its joint venture Kronans Apotek

Oriola
Regulatory press release12/11/2024, 7:15 AM

Oriola Oyj: Oriola renews operating model and management team to accelerate strategy execution

Oriola
Press release11/20/2024, 8:00 AM

Oriola Oyj: The Swedish Patent and Market Court rejected Apotekstjänst Sverige AB's appeal regarding the sale of Svensk dos AB

Oriola
Oriola Q3’24: Building the foundation
Video10/30/2024, 1:15 PM by
Rauli Juva

Oriola Q3’24: Building the foundation

Changes in Oriola’s management group continued, with the focus now on creating a sustainable foundation. Despite achieving strong revenue growth, Oriola unexpectedly recorded substantial one-time costs related to the ERP project.

Oriola
Oriola-KD Oyj, Q3'24
Webcast10/30/2024, 8:00 AM

Oriola-KD Oyj, Q3'24

Oriola
Regulatory press release10/30/2024, 6:30 AM

Oriola Oyj: Oriola Corporation's Interim Report January-September 2024

Oriola
Press release10/16/2024, 6:00 AM

Oriola Oyj: Oriola Corporation to publish its Interim Report for January-September 2024 on 30 October 2024

Oriola
Regulatory press release10/11/2024, 5:30 AM

Oriola Oyj: Change in Oriola Management Team: Hannes Hasselrot, Chief Commercial Officer, to leave Oriola

Oriola
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Privacy preferences

Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.